Searchable abstracts of presentations at key conferences in endocrinology

ea0067o43 | Oral Presentations | EYES2019

Vitamin D deficiency in pregnant women in Russia Federation

Rybakova Anastasia , Platonova Nadezhda , Troshina Ekaterina , Nikankina Larisa

Pregnant women are at risk of developing diseases associated with deficiency of essential micronutrients.Objective: To assess the prevalence of vitamin D deficiency among pregnant women and its dependence on the trimester of pregnancy.Methods: We examined 476 pregnant women at different gestational periods from three regions of Russia (Moscow, Ivanovo, Smolensk). Concentration of 25(OH)vitamin D (ng/ml) was estimated by immunometri...

ea0063p15 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Immunohistochemical characteristics of adrenal tumors in patients with primary aldosteronism

Romanova Natalia , Selivanova Lilya , Platonova Nadezhda , Troshina Ekaterina , Abrosimov Aleksandr

Introduction: CYP11B2 is a key enzyme of primary aldosteronism, and several factors are involved in the regulation of CYP11B2 expression and the overproduction of aldosterone. Somatic mutations in aldosterone-driver genes are strongly associated with CYP11B2 expression and have been only detected in the CYP11B2-positive tumor area, indicating that aldosterone producing adenoma (APA) intratumoral heterogeneity corresponds to non-uniform CYP11B2 expression in neoplastic cells. I...

ea0063p549 | Diabetes, Obesity and Metabolism 2 | ECE2019

PRIMAVERA study: sibutramine therapy safety monitoring in patients with obesity

Troshina Ekaterina , Mazurina Natalya , Galieva Marina , Melnichenko Galina , Dedov Ivan

Objective: The aim of the study was to assess the effectiveness and safety of long-term sibutramine therapy in routine clinical practice.Materials and methods: In total, 98 774 patients (82.3% women, 17.7% men), from 142 cities of the Russian Federation were enrolled in the PRIMAVERA program. The mean age of the patients was 39.39±10.38 years, the mean body weight was 99.1±14.28 kg, and the mean BMI was 35.7±4.41 kg/m2. Physicia...

ea0063p937 | Diabetes, Obesity and Metabolism 3 | ECE2019

MicroRNA-26a, microRNA-33a, and microRNA-33b in patients with obesity: association with coronary artery disease

Shvangiradze Teona , Bondarenko Irina , Troshina Ekaterina , Karpukhin Aleksandr

Introduction: Obesity and type 2 diabetes mellitus (T2DM) are commonly associated with coronary artery disease (CAD). Recent studies demonstrated that microRNAs (miRNAs) are involved in the pathogenesis of CAD.Aim: To study miRNA-26a, microRNA-33a and microRNA-33b expression in patients with obesity.Methods: MiRNAs were detected in peripheral blood samples of 66 patients, aged 48–65 years. Patients with BMI 30.0–39.9 kg/m...

ea0063ep143 | Thyroid | ECE2019

Clinical case of giant goiter with chronic lymphoid leukemia

Romanova Natalia , Platonova Nadezhda , Troshina Ekaterina , Voskoboynikov Valeriy , Abrosimov Aleksandr

Introduction: Lymphoma of the thyroid gland is an uncommon condition occurring primarily in older women. Most patients have a short history of enlarging thyroid or a neck mass causing tracheal compression. There is also a strong association between thyroid lymphoma and Hashimoto’s thyroiditis. The diagnosis is established by biopsy. The conventional approach to treatment is combination of radiation therapy with multi-agent chemotherapy, while there is no significant role ...

ea0049ep659 | Obesity | ECE2017

MicroRNAs, associated with coronary heart disease in patients with obesity and diabetes mellitus type 2

Shvangiradze Teona , Bondarenko Irina , Troshina Ekaterina , Shestakova Marina

Introduction: Obesity and diabetes mellitus type 2 (T2DM) are considered as one of the major risk factor for coronary heart disease (CHD) development, but the mechanisms beyond this relationship still need to be clarified. miRNAs are supposed to be involved in regulatory mechanisms in this relationship.Aim: To determine miRNAs expression in patients with obesity and T2DM.Methods: MiRNAs were detected in peripheral blood of 43 patie...

ea0049ep685 | Obesity | ECE2017

Association of Transforming growth factor β and Fibroblast growth factor 21 with cardiovascular diseases in obese patients

Shvangiradze Teona , Troshina Ekaterina , Bondarenko Irina , Shestakova Marina , Nikankina Larisa

Introduction: Obesity and type 2 diabetes mellitus (T2DM) are associated with cardiovascular diseases (CVD). Fibrotic changes in obesity include several molecular processes, including activation of Transforming growth factor β (TGF-β). Recent data indicate the involvement of Fibroblast growth factor 21 (FGF-21) as an important metabolic regulator, and even biomarker of metabolic changes in obesity and T2DM.Aim: To determine TGF-β and FGF-2...

ea0037ep546 | Obesity and cardiovascular endocrinology | ECE2015

Glucose metabolism regulation in morbidly obese patients and in patients after biliopancreatic diversion

Mazurina Natalya , Troshina Ekaterina , Ogneva Natalya , Yashkov Yuri

Introduction: Morbid obesity (MO) is associated with high frequency of type 2 diabetes mellitus (T2DM). Biliopancreatic diversion (BPD) is bariatric operation that results in rapid T2DM remission and increased GLP-1 levels. The aim of the study was to compare non-diabetic MO patients with normal weight controls and with patients who underwent BPD more than 2 years ago.Methods: Blood glucose levels, IRI, GLP-1, GIP and glucagon were measured during the or...

ea0037ep553 | Obesity and cardiovascular endocrinology | ECE2015

The functional parameters of renin-angiotensin-aldosterone system in obese patients

Platonova Nadezhda , Mazurina Natalya , Shvangiradze Teona , Troshina Ekaterina , Katzia Gulnara

Introduction: Renin-angiotensin-aldosterone system (RAAS) plays a significant role in the development of arterial hypertension (AH) in obese patient. Angiotensinogen expression in adipose tissue decreases during fasting and increases in case of overeating, that leads to changes in blood pressure (BP). The aim of the study was to assess the impact of obesity on the activity of RAAS and its role in the development of hypertension.Methods: 60 women, mean ag...

ea0070aep272 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Difficulties in diagnosing of artificial hypoglycemia: Insulin analogues

Yukina Marina , Nuralieva Nurana , Troshina Ekaterina , Malysheva Natalia , Nikankina Larisa

Introduction: One of the manifestations of Munchausen syndrome is the deliberate injection of insulin to achieve hypoglycemia or artificial hypoglycemia. If human insulin is injected, we will always determine high level of insulin and low level of Cpeptideatthemomentofhypoglycemia. Incasesof insulin analogues injection the diagnos is maybe difficult when we use analyzers specific only to human insulin: the low level of IRI and C peptide will be determined.<p class="abstext...